These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30649057)

  • 1. Point-of-care C-reactive protein and risk of early mortality among adults initiating antiretroviral therapy.
    Chaisson LH; Semitala FC; Asege L; Mwebe S; Katende J; Nakaye M; Andama AO; Marquez C; Atuhumuza E; Kamya M; Cattamanchi A; Yoon C
    AIDS; 2019 Apr; 33(5):895-902. PubMed ID: 30649057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for early mortality on antiretroviral therapy in advanced HIV-infected adults.
    Bisson GP; Ramchandani R; Miyahara S; Mngqibisa R; Matoga M; Ngongondo M; Samaneka W; Koech L; Naidoo K; Rassool M; Kirui F; Banda P; Mave V; Kadam D; Leger P; Henestroza G; Manabe YC; Bao J; Kumwenda J; Gupta A; Hosseinipour MC;
    AIDS; 2017 Oct; 31(16):2217-2225. PubMed ID: 28742529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Point-of-care C-reactive protein-based tuberculosis screening for people living with HIV: a diagnostic accuracy study.
    Yoon C; Semitala FC; Atuhumuza E; Katende J; Mwebe S; Asege L; Armstrong DT; Andama AO; Dowdy DW; Davis JL; Huang L; Kamya M; Cattamanchi A
    Lancet Infect Dis; 2017 Dec; 17(12):1285-1292. PubMed ID: 28847636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of hematocrit on point-of-care C-reactive protein-based tuberculosis screening among people living with HIV initiating antiretroviral therapy in Uganda.
    Mwebe SZ; Yoon C; Asege L; Nakaye M; Katende J; Andama A; Cattamanchi A; Semitala FC
    Diagn Microbiol Infect Dis; 2021 Mar; 99(3):115281. PubMed ID: 33453673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Levels of Neopterin and C-Reactive Protein (CRP) in Tuberculosis (TB) with and without HIV Coinfection in Relation to CD4 Cell Count.
    Skogmar S; Schön T; Balcha TT; Sturegård E; Jansson M; Björkman P
    PLoS One; 2015; 10(12):e0144292. PubMed ID: 26630153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Point-of-care C-reactive protein testing to facilitate implementation of isoniazid preventive therapy for people living with HIV.
    Yoon C; Davis JL; Huang L; Muzoora C; Byakwaga H; Scibetta C; Bangsberg DR; Nahid P; Semitala FC; Hunt PW; Martin JN; Cattamanchi A
    J Acquir Immune Defic Syndr; 2014 Apr; 65(5):551-6. PubMed ID: 24346636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determine TB-LAM point-of-care tuberculosis assay predicts poor outcomes in outpatients during their first year of antiretroviral therapy in South Africa.
    Kerkhoff AD; Longley N; Kelly N; Cross A; Vogt M; Wood R; Hermans S; Lawn SD; Harrison TS
    BMC Infect Dis; 2020 Jul; 20(1):555. PubMed ID: 32736601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early immunologic failure is associated with early mortality among advanced HIV-infected adults initiating antiretroviral therapy with active tuberculosis.
    Ravimohan S; Tamuhla N; Steenhoff AP; Letlhogile R; Makutu DK; Nfanyana K; Rantleru T; Tierney A; Nkakana K; Schwartz AB; Gross R; Macgregor RR; Bellamy SL; Frank I; Weissman D; Bisson GP
    J Infect Dis; 2013 Dec; 208(11):1784-93. PubMed ID: 23908475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis.
    Blanc FX; Sok T; Laureillard D; Borand L; Rekacewicz C; Nerrienet E; Madec Y; Marcy O; Chan S; Prak N; Kim C; Lak KK; Hak C; Dim B; Sin CI; Sun S; Guillard B; Sar B; Vong S; Fernandez M; Fox L; Delfraissy JF; Goldfeld AE;
    N Engl J Med; 2011 Oct; 365(16):1471-81. PubMed ID: 22010913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study.
    Katz IT; Kaplan R; Fitzmaurice G; Leone D; Bangsberg DR; Bekker LG; Orrell C
    PLoS Med; 2017 Nov; 14(11):e1002434. PubMed ID: 29136014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Causes and determinants of mortality in HIV-infected adults with tuberculosis: an analysis from the CAMELIA ANRS 1295-CIPRA KH001 randomized trial.
    Marcy O; Laureillard D; Madec Y; Chan S; Mayaud C; Borand L; Prak N; Kim C; Lak KK; Hak C; Dim B; Sok T; Delfraissy JF; Goldfeld AE; Blanc FX;
    Clin Infect Dis; 2014 Aug; 59(3):435-45. PubMed ID: 24759827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality and its determinants in antiretroviral treatment-naive HIV-infected children with suspected tuberculosis: an observational cohort study.
    Marcy O; Tejiokem M; Msellati P; Truong Huu K; Do Chau V; Tran Ngoc D; Nacro B; Ateba-Ndongo F; Tetang-Ndiang S; Ung V; Dim B; Neou L; Berteloot L; Borand L; Delacourt C; Blanche S;
    Lancet HIV; 2018 Feb; 5(2):e87-e95. PubMed ID: 29174612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial.
    Hosseinipour MC; Bisson GP; Miyahara S; Sun X; Moses A; Riviere C; Kirui FK; Badal-Faesen S; Lagat D; Nyirenda M; Naidoo K; Hakim J; Mugyenyi P; Henostroza G; Leger PD; Lama JR; Mohapi L; Alave J; Mave V; Veloso VG; Pillay S; Kumarasamy N; Bao J; Hogg E; Jones L; Zolopa A; Kumwenda J; Gupta A;
    Lancet; 2016 Mar; 387(10024):1198-209. PubMed ID: 27025337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of integrated treatment for tuberculosis and HIV in children at the primary health care level.
    Patel MR; Yotebieng M; Behets F; Vanden Driessche K; Nana M; Van Rie A
    Int J Tuberc Lung Dis; 2013 Sep; 17(9):1206-11. PubMed ID: 23827656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immediate Antiretroviral Therapy Decreases Mortality Among Patients With High CD4 Counts in China: A Nationwide, Retrospective Cohort Study.
    Zhao Y; Wu Z; McGoogan JM; Shi CX; Li A; Dou Z; Ma Y; Qin Q; Brookmeyer R; Detels R; Montaner JSG
    Clin Infect Dis; 2018 Feb; 66(5):727-734. PubMed ID: 29069362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.
    ; Danel C; Moh R; Gabillard D; Badje A; Le Carrou J; Ouassa T; Ouattara E; Anzian A; Ntakpé JB; Minga A; Kouame GM; Bouhoussou F; Emieme A; Kouamé A; Inwoley A; Toni TD; Ahiboh H; Kabran M; Rabe C; Sidibé B; Nzunetu G; Konan R; Gnokoro J; Gouesse P; Messou E; Dohoun L; Kamagate S; Yao A; Amon S; Kouame AB; Koua A; Kouamé E; Ndri Y; Ba-Gomis O; Daligou M; Ackoundzé S; Hawerlander D; Ani A; Dembélé F; Koné F; Guéhi C; Kanga C; Koule S; Séri J; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatounde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Assi R; Bakayoko A; Mahassadi A; Attia A; Oussou A; Mobio M; Bamba D; Koman M; Horo A; Deschamps N; Chenal H; Sassan-Morokro M; Konate S; Aka K; Aoussi E; Journot V; Nchot C; Karcher S; Chaix ML; Rouzioux C; Sow PS; Perronne C; Girard PM; Menan H; Bissagnene E; Kadio A; Ettiegne-Traore V; Moh-Semdé C; Kouame A; Massumbuko JM; Chêne G; Dosso M; Domoua SK; N'Dri-Yoman T; Salamon R; Eholié SP; Anglaret X
    N Engl J Med; 2015 Aug; 373(9):808-22. PubMed ID: 26193126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study.
    Ravimohan S; Tamuhla N; Steenhoff AP; Letlhogile R; Nfanyana K; Bellamy SL; MacGregor RR; Gross R; Weissman D; Bisson GP
    Lancet Infect Dis; 2015 Apr; 15(4):429-38. PubMed ID: 25672566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean.
    Carriquiry G; Fink V; Koethe JR; Giganti MJ; Jayathilake K; Blevins M; Cahn P; Grinsztejn B; Wolff M; Pape JW; Padgett D; Madero JS; Gotuzzo E; McGowan CC; Shepherd BE
    J Int AIDS Soc; 2015; 18(1):20016. PubMed ID: 26165322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of C-reactive protein for tuberculosis, bloodstream infection or death among HIV-infected individuals with chronic, non-specific symptoms and negative sputum smear microscopy.
    Bedell RA; van Lettow M; Meaney C; Corbett EL; Chan AK; Heyderman RS; Anderson ST; Åkesson A; Kumwenda M; Zachariah R; Harries AD; Ramsay AR
    Trop Med Int Health; 2018 Mar; 23(3):254-262. PubMed ID: 29243878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled Trial.
    Rosen S; Maskew M; Fox MP; Nyoni C; Mongwenyana C; Malete G; Sanne I; Bokaba D; Sauls C; Rohr J; Long L
    PLoS Med; 2016 May; 13(5):e1002015. PubMed ID: 27163694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.